ArticleJournal of breast cancer2018

Isomangiferin, a Novel Potent Vascular Endothelial Growth Factor Receptor 2 Kinase Inhibitor, Suppresses Breast Cancer Growth, Metastasis and Angiogenesis.

Banghua Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.